2023: The Best Year Ever for Future Pharmacology (and Even Better Years to Come)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

2023: The Best Year Ever for Future Pharmacology (and Even Better Years to Come)

Published:2024-01-02 Issue:1 Volume:4 Page:1-2
ISSN:2673-9879
Container-title:Future Pharmacology
language:en
Short-container-title:Future Pharmacology

Author:

Schifano Fabrizio¹^ORCID

Affiliation:

1. Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK

Abstract

The end of any year provides an opportunity to reflect on the past, and in particular, the past twelve months [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2673-9879/4/1/1/pdf

Reference8 articles.

1. (2023, December 12). Future Pharmacology: Volume 3. Available online: https://www.mdpi.com/2673-9879/3.

2. Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions;Marques;Future Pharmacol.,2023

3. Bempedoic Acid and Statins in Lipid-Lowering Strategy: Which Came First, the Egg or the Chicken?;Natale;Future Pharmacol.,2023

4. Aspirin Therapy, Cognitive Impairment, and Dementia—A Review;Thong;Future Pharmacol.,2023

5. (2023, December 12). Pharmacology and Toxicology of Amphetamine Type Stimulants. Available online: https://www.mdpi.com/about/announcements/5783.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP